The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 132, No 2, 177-185.
© 2001 American Dental Association

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MALAMED, S. F.
Right arrow Articles by LEBLANC, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MALAMED, S. F.
Right arrow Articles by LEBLANC, D.
Related Collections
Right arrow Pharmacology

RESEARCH

Articaine hydrochloride: a study of the safety of a new amide local anesthetic



STANLEY F. MALAMED, D.D.S., SUZANNE GAGNON, M.D. and DOMINIQUE LEBLANC, D.Pharm.

Background. Articaine is an amide local anesthetic introduced clinically in Germany in 1976 and subsequently throughout Europe, Canada and, in 2000, the United States.

Methods. The authors report on three identical single-dose, randomized, double-blind, parallel-group, active-controlled multicenter studies that were conducted to compare the safety and efficacy of articaine (4 percent with epinephrine 1:100,000) with that of lidocaine (2 percent with epinephrine 1:100,000).

Results. A total of 1,325 subjects participated in these studies, 882 of whom received articaine 4 percent with epinephrine 1:100,000 and 443 of whom received lidocaine 2 percent with epinephrine 1:100,000. The overall incidence of adverse events in the combined studies was 22 percent for the articaine group and 20 percent for the lidocaine group. The most frequently reported adverse events in the articaine group, excluding postprocedural dental pain, were headache (4 percent), facial edema, infection, gingivitis and paresthesia (1 percent each). The incidence of these events was similar to that reported for subjects who received lidocaine. The adverse events most frequently reported as related to articaine use were paresthesia (0.9 percent), hypesthesia (0.7 percent), headache (0.55 percent), infection (0.45 percent), and rash and pain (0.3 percent each).

Conclusions. Articaine is a well-tolerated, safe and effective local anesthetic for use in clinical dentistry.




This article has been cited by other articles:


Home page
J Child NeurolHome page
M. M. Segal, G. F. Rogers, H. L. Needleman, and C. A. Chapman
Hypokalemic Sensory Overstimulation
J Child Neurol, December 1, 2007; 22(12): 1408 - 1410.
[Abstract] [PDF]


Home page
J Clin PharmacolHome page
M. Grossmann, G. Sattler, H. Pistner, R. Oertel, K. Richter, S. Schinzel, and L.-D. Jacobs
Pharmacokinetics of Articaine Hydrochloride in Tumescent Local Anesthesia for Liposuction
J. Clin. Pharmacol., November 1, 2004; 44(11): 1282 - 1289.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
T. A. King, J. Mitchell, K. Altman, M. Ozdemir, and K. G. Allman
Articaine for sub-Tenon's and peribulbar anaesthesia in cataract surgery
Br. J. Anaesth., October 1, 2004; 93(4): 595 - 596.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright©1995-2001 American Dental Association (ADA).
Reproduction or republication strictly prohibited without prior written permission of ADA.